Cancer cells showing high levels of the truncated NK-1R form are highly responsive to NK-1R antagonists, and this could be important for the specific and safe use of NK-1R antagonists since tumor cells express more of this form than normal cells [103]. The gene discussed is TACR1; the disease is cancer.